CD19- and BCMA-targeting CAR-T therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19- and BCMA-targeting CAR-T therapy, covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants [EARLY_Phase 1]